EVH / Evolent Health: Business Economics Still Appealing, Reiterate Buy

Evolent Health, Inc. (NYSE:EVH ) Q3 2023 Earnings Conference Call November 2, 2023 5:00 PM ET Company Participants Seth Frank - Vice President, Invest more_horizontal

Evolent Health (EVH) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to ea more_horizontal

WASHINGTON , Oct. 10, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with comp more_horizontal

Evolent Health (EVH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive more_horizontal

Evolent Health, Inc., is a mid-cap solutions provider in the healthcare space that made a major acquisition late last year. The stock is down some 30% more_horizontal

Evolent Health, Inc. (NYSE:EVH ) Q2 2023 Earnings Conference Call August 2, 2023 5:00 PM ET Company Participants Seth Frank – Vice President-Investo more_horizontal

Evolent Health's sales and profitability are creeping back above pre-pandemic levels. The company's recent acquisitions have added incremental value, more_horizontal

Evolent Health, Inc. (NYSE:EVH ) Q1 2023 Results Conference Call May 3, 2023 5:00 PM ET Company Participants Seth Frank - VP, IR Seth Blackley - CEO J more_horizontal